AI Development for Healthcare :

Healthcare AI Use Cases We Build

Healthcare AI deployments cluster around five common patterns. We have implementation experience in each.

• Clinical documentation assistants: AI agents that summarize patient encounters, draft progress notes, and extract structured data from clinician dictation. PHI-heavy, high audit scrutiny.
• Patient-facing chat and triage: AI applications that interact directly with patients for symptom intake, appointment scheduling, and post-visit follow-up. Cross-tenant isolation critical.
• Revenue cycle automation: AI agents that handle prior authorization, claims processing, denial management. Requires payer system integration and audit trail.
• Clinical decision support: AI augmentation of provider workflows for diagnosis assistance, treatment planning, drug interaction checking. Requires explainability and audit.
• Pharma and life sciences AI: trial recruitment, adverse event detection, regulatory submission preparation. FDA submission considerations layered onto HIPAA.

Why Healthcare AI Is Different

Three structural differences make healthcare AI harder than general enterprise AI. First, the data classification is unforgiving: PHI exposure carries direct regulatory liability and HHS Office for Civil Rights enforcement. Second, the procurement cycle is long: health systems average 9 to 18 months from first conversation to signed contract, with BAA review and security questionnaire processes that consume engineering time. Third, the inference provider constraints are real: only certain AI providers offer HIPAA-eligible deployments, and the choice has cascading implications for cost, latency, and feature availability.

Compliance Frameworks We Cover

Healthcare AI vendors typically need at least HIPAA attestation. Larger health systems increasingly require HITRUST CSF certification on top.

• HIPAA Privacy Rule and Security Rule: technical safeguards (164.312), administrative safeguards (164.308), physical safeguards (164.310)
• HIPAA Breach Notification Rule: incident response runbooks and 60-day notification procedures
• HITRUST CSF r2: 800+ control implementation for large health system distribution
• HITRUST CSF i1 or e1: faster path for smaller deployments or distribution to specialty practices
• FDA 21 CFR Part 11: electronic records and signatures for clinical trial data
• State-level requirements: California CMIA, Texas HB 300, New York SHIELD Act overlap

Inference Provider Stack for Healthcare

Three valid paths for healthcare AI inference, each with documented data flow and BAA chain.

• Anthropic Claude via Amazon Bedrock or Google Vertex AI: HIPAA-eligible inference with cloud provider BAA. Anthropic does not train on customer data. Default for new healthcare engagements.
• Azure OpenAI Service: HIPAA-eligible OpenAI access with Microsoft BAA. Required when Microsoft is the customer's preferred cloud or when the application lives in the Microsoft ecosystem.
• Self-hosted open-weight models: Llama, Mistral, Qwen variants self-hosted on AWS, Azure, or on-premises. Full control, no third-party BAA required, higher engineering cost.

What LYFYE Brings

Founder-led engagement led by senior operators with healthcare AI implementation experience. Direct access to the engineer designing your boundary, not handoff to a junior team. Engagement model includes HIPAA risk assessment, architecture design, sprint-based development, pre-attestation readiness, and optional HITRUST CSF readiness extension. We work with HIPAA-experienced audit firms and HITRUST authorized assessors and can introduce you to the right partner for your stage.

What LYFYE Does Not Do

We do not build wellness apps or general consumer health apps that do not handle PHI; those are well-served by generalist agencies at lower cost. We do not handle direct EMR system replatforming or large-scale Epic or Cerner integration projects; those require specialized health IT integrators with multi-year platform expertise. We do not pursue HITRUST CSF certification for vendors who don't have a clear health system buyer requirement; the cost is significant and not worth pursuing speculatively.

Typical Engagement Profile

Most healthcare AI engagements run 6 to 12 months from kickoff to first BAA-ready release.

• Healthtech startup, Series A or B, building first product for health system distribution: $400K to $900K, 6 to 9 months
• Health system innovation team, internal AI application: $300K to $700K, 5 to 8 months
• Pharma or device company, AI features added to existing commercial product: $250K to $600K, 4 to 7 months
• Enterprise health IT vendor, AI category entry: $500K to $1.2M, 8 to 12 months

Related Services and Briefings

If you are evaluating LYFYE for healthcare AI work, these related resources are worth reading: HIPAA Compliance for AI Applications (definitive guide), Secure Agentic Runtime (reference architecture), Audit Ready AI Systems (reference architecture), HIPAA-Compliant AI Development (service page).

How to Engage

30-minute scoping call to confirm fit. Bring your target buyer profile, target compliance bar (HIPAA only or HITRUST CSF target), and current technical context. We will tell you directly if your project is better served by another partner.